Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02511795
Title AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Research Site Denver Colorado 80218 United States Details
Research Site Sarasota Florida 34232 United States Details
Research Site New York New York 10033 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field